Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Agomelatine SPC

The Summary of Product Characteristics for agomelatine (Valdoxan®) is now available via the electronic Medicines Compendium (eMC).

As previously discussed, agomelatine is a new class of antidepressant. The SPC gives more details for this drug including known side effects, precautions and interactions.

Action: Clinicians who are considering using this new drug would be wise to review the SPC before starting a treatment.

Share 'Agomelatine SPC' on Email Share 'Agomelatine SPC' on Delicious Share 'Agomelatine SPC' on Digg Share 'Agomelatine SPC' on Facebook Share 'Agomelatine SPC' on Google+ Share 'Agomelatine SPC' on reddit Share 'Agomelatine SPC' on StumbleUpon Share 'Agomelatine SPC' on Twitter

atomic-wealth

No Comments to “Agomelatine SPC”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,621 spam comments.

atomic-wealth
fond-illness
summer